Advertisement

Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children

  • Hong-kui Yu
  • Bei XiaEmail author
  • Xiao Liu
  • Chunxi Han
  • Weiling Chen
  • Zhihui Li
Original Paper
  • 68 Downloads

Abstract

Three-dimensional (3D) speckle-tracking echocardiography (STE) is a new imaging modality used for quantitative analysis of left ventricular (LV) function. The aim of this study is to assess the value of 3D STE in early detection of subclinical myocardial involvement in children with Duchenne muscular dystrophy (DMD). Fifty-six children with DMD (mean age, 8.8 ± 1.9 years) and 31 age-matched control subjects were studied. Patients were subdivided into two groups by age: ≤ 8 or > 8 years. Standard echocardiography examinations were performed to measure LV size and ejection fraction (EF). 3D STE was performed to assess LV 3D global strain and LV end-diastolic volume (EDV), end-systolic volume (ESV), and EF. Standard and 3D echocardiography measures were compared between children with DMD and those in the control group as well as between different patient groups. The areas under the receiver-operating characteristic (ROC) curve were calculated to determine the capability of 3D global strain indices to discriminate between patients and control subjects. No significant difference was detected in either LVEF derived from M-mode or 3D echocardiography between the two groups, and they were both within the normal range. Compared with control subjects, children with DMD had significantly reduced LV 3D global longitudinal strain (GLS; − 16.6 ± 4.7 vs. − 19.5 ± 3.7, p = 0.003), global circumferential strain (GCS; − 13.7 ± 2.9 vs. − 15.8 ± 2.6, p = 0.001), global radial strain (GRS; 42.5 ± 9.7 vs. 50.3 ± 10.4, p = 0.001), and global area strain (GAS; − 25.3 ± 4.9 vs. − 30.7 ± 4.1, p = 0.000). The older DMD children (age > 8 years) had lower GLS (− 15.1 ± 4.43 vs. − 18.6 ± 4.35, p < 0.05), GCS (− 12.8 ± 3.48 vs. − 14.8 ± 2.83, p < 0.001), GAS (− 23.8 ± 4.7 vs. − 29.0 ± 5.4, p < 0.001), and GRS (40.7 ± 8.8 vs. 47.3 ± 11.5, p < 0.05) than younger patients (age ≤ 8 years). The AUC of GAS was 0.80, and the cutoff value of − 29.5 had a sensitivity of 85.7% and a specificity of 71.0% for differentiating DMD patients from control. 3D speckle-tracking echocardiography is useful for detecting subclinical myocardial dysfunction and stratifying cardiomyopathy in children with DMD.

Keywords

Three-dimensional speckle-tracking echocardiography Cardiomyopathy Duchenne muscular dystrophy Area strain Children 

Notes

Funding

This study was funded by Shenzhen Municipal Science and Technology Innovation Committee Foundation (No. JCYJ20140416141331487).

Compliance with ethical standards

Conflict of interest

The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Cohen N, Muntoni F (2004) Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy. Heart 90:835–841CrossRefGoogle Scholar
  2. 2.
    Biggar WD (2006) Duchenne muscular dystrophy. Pediatr Rev 27:83–88CrossRefGoogle Scholar
  3. 3.
    Muntoni F (2003) Cardiac complications of childhood myopathies. J Child Neurol 18:191–202CrossRefGoogle Scholar
  4. 4.
    Yiu EM, Kornberg AJ (2015) Duchenne muscular dystrophy. J Paediatr Child Health 51:759–764CrossRefGoogle Scholar
  5. 5.
    Eagle M, Baudouin SV, Chandler C, Giddings DR, Bullock R, Bushby K (2002) Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation. Neuromuscul Disord 12:926–929CrossRefGoogle Scholar
  6. 6.
    Spurney C, Shimizu R, Morgenroth LP, Kolski H, Gordish-Dressman H, Clemens PR (2014) Cooperative International Neuromuscular Research Group Duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50:250–256CrossRefGoogle Scholar
  7. 7.
    Towbin JA (2003) A noninvasive means of detecting preclinical cardiomyopathy in Duchenne muscular dystrophy? J Am Coll Cardiol 42:317–318CrossRefGoogle Scholar
  8. 8.
    Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD et al (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799–2804CrossRefGoogle Scholar
  9. 9.
    Mori K, Hayabuchi Y, Inoue M, Suzuki M, Sakata M, Nakagawa R et al (2007) Myocardial strain imaging for early detection of cardiac involvement in patients with Duchenne’s progressive muscular dystrophy. Echocardiography 24:598–608CrossRefGoogle Scholar
  10. 10.
    Ryan TD, Taylor MD, Mazur W, Cripe LH, Pratt J, King EC et al (2013) Abnormal circumferential strain is present in young Duchenne muscular dystrophy patients. Ped Cardiol 34:1159–1165CrossRefGoogle Scholar
  11. 11.
    Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R et al (2009) Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 53:1204–1210CrossRefGoogle Scholar
  12. 12.
    Schueler R, Sinning JM, Momcilovic D, Weber M, Ghanem A, Werner N et al (2012) Three-dimensional speckle-tracking analysis of left ventricular function after transcatheter aortic valve implantation. J Am Soc Echocardiogr 25(8):827–834CrossRefGoogle Scholar
  13. 13.
    Li SN, Wong SJ, Cheung YF (2011) Novel area strain based on three-dimensional wall motion analysis for assessment of global left ventricular performance after repair of tetralogy of Fallot. J Am Soc Echocardiogr 24:819–825CrossRefGoogle Scholar
  14. 14.
    Wen H, Liang Z, Zhao Y, Yang K (2011) Feasibility of detecting early left ventricular systolic dysfunction using global area strain: a novel index derived from three-dimensional speckle-tracking echocardiography. Eur J Echocardiogr 12:910–916CrossRefGoogle Scholar
  15. 15.
    Yamamoto T, Tanaka H, Matsumoto K, Lee T, Awano H, Yagi M et al (2013) Utility of transmural myocardial strain profile for prediction of early left ventricular dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 111:902–907CrossRefGoogle Scholar
  16. 16.
    Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M et al (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49:1874–1879CrossRefGoogle Scholar
  17. 17.
    Fong PY, Turner PR, Denetclaw WF, Steinhardt R (1990) Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science 250:673–676CrossRefGoogle Scholar
  18. 18.
    Williams IA, Allen DG (2007) The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 293:H1969–H1977CrossRefGoogle Scholar
  19. 19.
    Shigihara-Yasuda K, Tonoki H, Goto Y, Arahata K, Ishikawa N, Kajii N et al (1992) A symptomatic female patient with Duchenne muscular dystrophy diagnosed by dystrophin-staining: a case report. Eur J Pediatr 151:66–68CrossRefGoogle Scholar
  20. 20.
    Finsterer J, Stollberger C (2003) The heart in human dystrophinopathies. Cardiology 99:11–19CrossRefGoogle Scholar
  21. 21.
    Cheung YF (2012) The role of 3D wall motion tracking in heart failure. Nat Rev Cardiol 9:644–657CrossRefGoogle Scholar
  22. 22.
    Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M et al (2004) Two-dimensional strain—a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr 17:1021–1029CrossRefGoogle Scholar
  23. 23.
    Amundsen BH, Helle-Valle T, Edvardsen T, Torp H, Crosby J, Lyseggen E et al (2006) Noninvasive myocardial strain measurement by speckle tracking echocardiography: validation against sonomicrometry and tagged magnetic resonance imaging. J Am Coll Cardiol 47:789–793CrossRefGoogle Scholar
  24. 24.
    Yu HK, Yu W, Cheuk DK, Wong SJ, Chan GC, Cheung YF (2013) New three-dimensional speckle- tracking echocardiography identifies global impairment of left ventricular mechanics with a high sensitivity in childhood cancer survivors. J Am Soc Echocardiogr 26:846–852CrossRefGoogle Scholar
  25. 25.
    Yu W, Wong SJ, Cheung YF (2014) Left ventricular mechanics in adolescents and young adults with a history of kawasaki disease: analysis by three-dimensional speckle tracking echocardiography. Echocardiography 31:483–491CrossRefGoogle Scholar
  26. 26.
    Saha SK, Kiotsekoglou A, Toole RS, Moggridge JC, Nichols KJ, Govind S et al (2012) Value of two-dimensional speckle tracking and real time three-dimensional echocardiography for the identification of subclinical left ventricular dysfunction in patients referred for routine echocardiography. Echocardiography 29:588–597CrossRefGoogle Scholar
  27. 27.
    Christopher F, McCaffrey FM, Cnaan A, Morgenroth LP, Ghelani SJ, Gordish-Dressman H et al (2015) Feasibility and reproducibility of echocardiographic measures in children with muscular dystrophies. J Am Soc Echocardiogr 28:999–1008CrossRefGoogle Scholar
  28. 28.
    Gorcsan J-rd, Tanaka H (2011) Echocardiographic assessment of myocardial strain. J Am Coll Cardiol 58:1401–1413CrossRefGoogle Scholar
  29. 29.
    Huang BT, Yao HM, Huang H (2014) Left ventricular remodeling and dysfunction in systemic lupus erythematosus: a three-dimensional speckle tracking study. Echocardiography 31:1085–1094CrossRefGoogle Scholar
  30. 30.
    Dec GW (2013) Steroid therapy effectively delays Duchenne’s cardiomyopathy. J Am Coll Cardiol 61:955–956CrossRefGoogle Scholar
  31. 31.
    Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM (2005) Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 45:855–857CrossRefGoogle Scholar
  32. 32.
    Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A et al (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years’ follow-up. Am Heart J 154:596–602CrossRefGoogle Scholar
  33. 33.
    Janssen PM, Murray JD, Schill KE, Rastogi N, Schultz EJ, Tran T et al (2014) Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy. PLoS ONE 9(2):e88360CrossRefGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  1. 1.Department of UltrasonographyShenzhen Children’s HospitalShenzhenChina
  2. 2.Laboratory of Neuromuscular DiseaseShenzhen Children’s HospitalShenzhenChina

Personalised recommendations